Logo UMG Nadpis UMG

Grant projects implemented at IMG in 2012

    2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012

 

GRANT 
AGENCY

GRANT´S NUMBER

THE GRANT´S NAME

SCHEDULE

GRANT´S
CO-ORDINATOR

GROUP

GA ČR

GAP301/10/2174

Epigenetic mechanisms in regulativ of genes important for antigen presentation 

and antitumour immunity

2010-2013

M. Reiniš

11

GA ČR

GPP301/11/P220

Mechanisms underlying cyclophosphamide-induced accumulation of myeloid 

derived suppressor cells

2011-2013

R. Mikyšková

11

GA ČR

GAP502/10/1651

Characterization of new avian sarcoma and leukosis virus (ASLV) receptor 

alleles as revealed by the analysis of semiresistant cells

2010-2012

J. Plachý

12

GA ČR

P502/11/2207

Avian Sarcoma and Leukosis Virus-based Vectors and Their Potential for Transgenesis in chicken

2011-2013

J. Hejnar

12

GA ČR

GAP304/12/1736

Development of CpG methylation of HIV-1 promoter and its stabilizing effect on the latent provirus reservoir: longitudinal study in patients

2012-2014

K. Trejbalová

12

MŠMT

LK11215

Regulation of active endogenous retroviruses in the mammalian genome

2012-2016

D. Elleder

12

MZE

QJ1210041

A novel type of vaccine for attenuation of viral diseases in poultry

2012-2016

J. Hejnar

(spoluřeš.)

12

GA ČR

GA310/09/2084

Characterization of the molecular machinery regulating the recruitment 

of signaling molecules to lipid rafts

2009-2013

D. Filipp

13

GA ČR

P302/12/G101

Molecular mechanisms of leukocyte receptor signalling – their role in health and disease

2012-2018

V. Hořejší (+ Pe. Dráber

+ D. Filipp)

13

GA ČR

GA303/08/1591

Study of glutamate receptors conformational changes using novel fluorescent techniques

2008-2012

J. Blahoš

14

GA ČR

GAP303/12/2408

Functional consequences of metabotropic glutamate receptor 1a and 1b splice variants assebmly in heterodimeric complexes

2012-2016

J. Blahoš

14

GA ČR

GA310/08/1697

First genetic model for analysis of susceptibility to parasite Leishmania tropica: potential implications for studies of human leishmaniases

2008-2012

M. Lipoldová

15

GA ČR

GAP502/11/2116

Differences in clinical course of tick-borne encephalitis in host, and their genetic determination

2011-2015

M. Lipoldová (spoluřeš.)

15

MŠMT

LH12049

New genomic strategy for fast identification of genes controlling development of infectious diseases and cancer

2012-2015

M. Lipoldová

15

AV ČR

KAN200520801

Targeted expression and transport of bioactive molecules

2008-2012

D. Staněk

16

GA ČR

GAP305/10/0424

Regulation of alternative splicing via chromatin acetylation

2010-2013

D. Staněk

16

GA ČR

GAP302/11/1910

Formation of splicing machinery in the context of the cell nucleus

2011-2014

D. Staněk

16

GA ČR

P305/12/G034

Centre for RNA biology

2012-2018

D. Staněk
(+ Pe. Svoboda) (spoluřeš.)

16

 

GA ČR

GPP301/12/P425

Functional analysis of hBrr2 mutations linked to retinitis pigmentosa

2012-2014

Z. Cvačková

16

GA AV ČR

IAA500520812

Investigating the pathologic role of metalloproteinases in liver using transgenic mice with conditional expression of transgenes

2008-2012

R. Sedláček

18

GA ČR

GAP305/10/2143

Generation of mouse models for targeting stelete cells and myofibroblasts in the liver

2010-2013

R. Sedláček

18

GA ČR

GAP303/10/2044

The Impact of a liver-specific deficiency of growth factor sheddase ADAM10 on liver development and pathology

2010-2013

R. Sedláček

18

GA ČR

GAP302/11/2048

Function of metalloproteinases in colon epithelium and during development of experimental colitis and colon cancer

2011-2014

R. Sedláček

18

OPVK

CZ.1.07/2.3.00/20.0102

Formation of an expert phenogenomics team

2011-2014

R. Sedláček

18

OPVK

CZ.1.07/2.3.00/30.0027

Establishment of a centre of transgenic technologies

 

R. Sedláček

18

MŠMT

Rada pro velké infrastruktury pro 

výzkum, vývoj a inovace

Infrafrontier-CZ/Czech Centre for Phenogenomics as a national centre of the “European Infrastructure for Phenotyping and Archiving Model Mammalian Genomes”: Integration of the Czech national centre into the international network – support of international activities

2012-2015

R. Sedláček

18

MŠMT

LK11213

Analysis of the Pin1 and CRMP2A genes and their impact on the growth, branching and regeneration of axons in vitro and in vivo

2012-2016

M. Balaštík

18

AV ČR

KAN200520804

Biocompatible nanofiber scaffolds forming novel drug matrices for the application of biologically and pharmacologically active substances

2008-2012

V. Holáň

 

19

GA ČR

GA206/08/0640

Host-parasite relationship, hybrid zone, immune systém, house mouse, Mus musculus

2008-2012

V. Holáň (spoluřeš.)

19

GA ČR

GAP304/11/0653

Targeted differentiation and transdifferentiation of limbal and mesenchymal stem cells and their therapeutic applications in preclinical models

2011-2014

V. Holáň

19

GA ČR

GAP301/11/1568

Cellular aspects of transplantation tolerance

2011-2014

V. Holáň (spoluřeš.)

19

GA ČR

GAP305/11/1780

Wnt signaling in self-renewal and tumorigenesis of the intestinal epithelia

2011-2014

V. Kořínek

20

GA ČR

GAP304/11/1252

Bacteria in etiology, prevention ant therapy of experimentally induced intestinal inflammation and colon cancer

2011-2014

V. Kořínek (spoluřeš.)

20

GA ČR

GAP305/12/2347

HIC1, Hypermethylated in cancer 1, gene targeting, tumors, expression prifiling, cellular signaling

2012-2015

V. Kořínek

20

MPO

TIP – FR-TI4/802

Development of novel chemical compounds that can be utilised in antitumour therapy and regenerative medicine

2012-

P. Bartůněk (+ V. Kořínek)

20

GA ČR

GD204/09/H058

Intercellular signalling in development and disease

 

2009-2012

Z. Kozmik (spoluřeš.)

(+ Kořínek)

20

AV ČR

 

Premium Academiae

Premium Academiae

2007-2013

J. Forejt

21

GA ČR

GAP305/10/1931

Identification of interactors of the meiotic histone methyltransferase Hybrid sterility 1 /PR-domain 9)

2010-2013

Z. Trachtulec

21

MŠMT

LD11079 (COST CZ)

New mouse models for the study of biomedical complex traits and human diseases for systemic genetics

2011-2014

J. Forejt

21

GA ČR

GPP305/11/P630

Epigenetic regulators of gene expression in mouse spermatogenesis

2011-2013

O. Mihola

21

GA ČR

GD204/09/H084

Molecular biology of a differentiating cell

 

2009-2012

P. Hozák (+ J. Forejt + Pe. Dráber + Pa. Dráber)

21

AV ČR

M200520901

Novel components of mast cell immune receptor signalling

2009-2012

Pe. Dráber

22

MPO

FR-TI3/067

Genetically modified polymerases and their utilization for amplification of non-purified DNA

2011-2014

Pe. Dráber

22

GA ČR

GA301/09/1826

Topography and function of Csk-binding proteins of the plasma membrane in mast cells 

2009-2013

Pe. Dráber

22

TA ČR

TA01010436

New generations of DNA aptamers

2011-2013

Pe. Dráber

22

GA ČR

GAP302/10/1759

Function-structure relationships between transmembrane adaptor-based signalosomes in mast cells

2010-2013

L. Dráberová

22

MŠMT

COST – LD12073

Membrane signalosomes of mast cells and basophiles – targets for innovative therapy

2012-2014

Pe. Dráber

22

GA ČR

P302/12/G101

Molecular mechanisms of leukocyte receptor signalling – their role in health and disease

2012-2018

V. Hořejší (+ Pe. Dráber + D. Filipp)

22

GA ČR

GD204/09/H084

Molecular biology of a differentiating cell

2009-2012

P. Hozák (+ J. Forejt + Pe. Dráber + Pa. Dráber)

22

GA ČR

GAP301/10/1971

Expression, signaling and function of Death Receptors in human embryonic stem cells

2010-2012

L. Anděra

23

MŠMT

LH12202

Analysis and inhibition of the mechanisms leading to resistance of tumour cells to the TRAIL ligand

2012-2015

L. Anděra

23

MZ ČR

NT/13201

Role of angiogenesis in the survival, growth, dissemination and therapeutic response of mantle cell lymphoma (MCL)

2012-2015

L. Anděra (spoluřeš.)

23

GA ČR

GEMEM/09/E011

Signaling and adaptor proteins of leukocyte membrane microdomains

2009-2012

V. Hořejší

24

GA ČR

GAP305/11/0459

The effect of transmembrane domains of integral proteins on dynamic organisation of the plasma membrane of T lymphocytes

2011-2014

T. Brdička (spoluřeš.)

24

GA ČR

GAP302/12/1712

Function of Csk-anchoring proteins SCIMP and PSTPIP2 in leukocyte signaling and inflammation

2012-2015

T. Brdička

24

GA ČR

P302/12/G101

Molecular mechanisms of signaling through leukocyte receptors their role in health and disease

2012-2018

V. Hořejší (+ Pe. Dráber

+ D. Filipp)

24

MZ ČR

NT/13271

Phenotyping of T- and B- lymphocytes in immunodeficient patients

2012-2015

T. Brdička (spoluřeš.)

24

MZ ČR

NT/13462

Optimization of immunotherapy and monitoring of minimal residual disease using flow cytometry in resistant acute lymphoblastic leukaemia

2012-2015

P. Otáhal (spoluřeš.)

24

GA ČR

GD204/09/H084

Molecular biology of a  differentiating cell

2009-2012

P. Hozák

25

GA ČR

GAP305/11/2232

Functions of myosin I and its binding partners in the cell nucleus

2011-2015

P. Hozák

25

 TA ČR

  TE01020118

  Electron microscopy

  2012-2019

  P. Hozák (spoluřeš)

  25

MPO

FR-TI3/588

Development of a kit for detection of mutations in structural proteins of a cell

2011-2015

P. Hozák

25

EU – FP7

262023

Euro-BioImaging: Research infrastructure for imaging technologies in biological and biomedical sciences

2011-2013

P. Hozák

25

MPO

FR-TI4/660

Multimodal holographic microscope

2012-2014

P. Hozák (spoluřeš.)

25

MŠMT

LD12063

New nuclear functions of central filaments

2012-2015

P. Hozák

25

MŠMT

LG12017

Provision of participation in the managing organs of the European and World Microscopy Society (EMS, IFSM)

2012-2015

P. Hozák

25

MŠMT

LE12004

Support of the Czech participation in pan-European research infrastructure Euro-Bioimaging

2012-2015

P. Hozák

25

MŠMT

LH12143

Contribution of actin and myosin protein families to chromatin dynamics and transcription in the cell nucleus

2012-2015

P. Hozák

25

GA ČR

GAP302/10/1701

Analysis of functional differences between gamma-tubulins

2010-2012

E. Dráberová

26

GA ČR

GPP302/11/P709

Analysis of microtubular changes during activation of mast cells

2011-2013

V. Sulimenko

26

GA ČR

GAP302/12/1673

Role of gamm-tubulin complexes in regulation of cell cycle progression

2012-2015

Pa. Dráber

26

GA ČR

GD204/09/H084

Molecular biology of a differentiating cell

2009-2012

P. Hozák (+ J. Forejt + Pe. Dráber + Pa. Dráber)

26

TACR

TA01010436

New generations of DNA aptamers

2011-2013

Pe. Dráber (+ Pa. Dráber)

26

MŠMT

LH12050

Regulation of microtubule formation in brain tumour cells

2012-2015

Pa. Dráber

26

GA ČR

GA204/09/0085

RNA silencing and long dsRNA in mammalian cells

2009-2013

P. Svoboda

28

GA ČR

GAP305/10/2215

Control of chromatin and pluripotency by microRNAs

2010-2013

P. Svoboda

28

MŠMT

ME09039

Role of posttranslational mechanisms in reprogramming mouse oocytes to pluripotent cells.

2009-2012

P. Svoboda

28

GA ČR

P305/12/G034

Centre for RNA biology

2012-2018

D. Staněk (+ Pe. Svoboda) (spoluřeš.)

 

28

 

GA AV ČR

IAA500520908

The role of Pax genes in eye evolution

2009-2013

Z. Kozmik

29

GA ČR

GD204/09/H058

Intercellular signalling in development of the organism and in disease genesis

2009-2012

Z. Kozmik (spoluřeš.)

29

GA ČR

GAP301/11/2198

Genetics of mammalian eye development

2011-2014

Z. Kozmik

29

GA ČR

GAP305/10/2141

Evolution of photoreceptors: insights from ancestral regulatory circuits

2010-2014

Z. Kozmik

29

GA ČR - Eurocores

GCP305/10/J064

Reconstructing urbilaterian photoreceptors: comparative study between Branchiostoma (Chordata) and Platynereis (Annelida)

2010-2012

Z. Kozmik (spoluřeš.)

29

GA ČR

GAP305/12/2042

The role of transcription factors Tcf in the induced cell pluripotency (iPS) and during neurogenesis

2012-2015

O. Machoň

29

MŠMT

LK11214

Genetic regulation of the brain and eye embryonic development

2012-2016

O. Machoň

29

MŠMT

LH12047

Role of alternative mRNA splicing in the evolution of body plan in vertebrates

2012-2015

Z. Kozmik

29

GA ČR

GA203/09/0820

Structurally inspired synthese of the selectiv inhibitors nukleotidas, potentially important medicals

2009-2013

J. Brynda

31

TA ČR

TA 02010797

Labelling of recombinant antibody fragments using microfluidics systems

2012-2014

J. Sedláček (spoluřeš.)

31

GA ČR

GCP305/10/J052

Functional analysis of endogenous retroviral elements in human genome: possible association with cancers

2010-2012

J. Pačes

33

GA ČR

GAP305/11/1061

Evolution of parasitism:analysis of genomes and key physiological functions of free-living Mastigamoeba balamuthi and pathogenic Entamoeba histolytica

2011-2015

J. Pačes (spoluřeš.)

33

GA ČR

GAP506/11/1317

Diversity and evolution of anaerobic Heterolobosea

2011-2014

Č. Vlček (spoluřeš.)

33

GA ČR

GAP506/11/1320

Establishment of the secondary plastid in euglenids

2011-2015

Č. Vlček (spoluřeš.)

33

GA ČR

GAP506/12/1010

Sequencing of  the oxymonad and trimastix genomes

2012-2014

V. Pačes (spoluřeš.)

33

GA ČR

GAP304/12/1333

Cell-to-cell interactions in malignant melanoma – experimental study

2012-2015

H. Strnad (spoluřeš.)

33

MZ ČR

NT/13488

Genomic analysis of tumour-associated fibroblasts in head and neck cancer: basis for a novel generation of biological antitumour therapy

2012-2015

H. Strnad (spoluřeš.)

33

MZ ČR

NT/13112

Study of the antitumour effects of statins

2012-2015

H. Strnad (spoluřeš.)

33

GA ČR

GA203/09/1311

Synthetic probes for recognition of tumor markers: applications for cell directed apoptosis and targeted photodynamic therapy

2009-2012

J. Králová

36

GA ČR

GAP305/10/2133

The study of satellite cells migration

2010-2012

P. Kašpar

36

GA ČR

GAP303/11/1291

New types of ligands interfering with cancer cell communication as a new therapeutic strategy

2011-2014

J. Králová (spoluřeš.)

36

AV ČR

KAN200520801

Targeted expression and transport of bioactive molecules

2008-2012

 D. Staněk (+ M. Dvořák)

 

36

 

EU - FP7

TRIREME 223575

Systems-Level, Multi-Layer Understanding of Cellular Responses to Ionizing Radiation

2009-2012

J. Bartek

37

GA ČR

GA204/08/1418

The role of the JAK/STATsignalling pathway in cellular senescence

2008-2012

Z. Hodný

 

37

GA ČR

GPP305/10/P420

Role of Wip1 phosphatase in the DNA damage response

2010-2012

L. Macůrek

37

GA ČR

GAP301/10/1525

Mechanisms of DNA damage checkpoint termination

2010-2012

J. Bartek

37

GA ČR

GPP305/11/P683

Post-translational modifications of Daxx and their functional relevance in DNA damage response and cellular senescence

2011-2013

H. Hanzlíková

37

GA ČR

GAP305/12/2485

Structure and function of proteins involved in DNA damage signaling

2012-2015

L. Macůrek

37

GA ČR

GA310/08/0878

The role of the cells prion protein in erytroidnic differentiation

2008-2012

P. Bartůněk (spoluřeš.)

38

GA ČR

GAP305/10/0953

New regulators of megakaryocyte and erythroid lineage commitment

2010-2013

P. Bartůněk

38

 

OPPK

CZ-OPENSCREEN

CZ.2.16/3.1.00/24020

National infrastructure for chemical biology

2011-

P. Bartůněk

38

GA ČR

GAP301/12/1478

The role of DISP3 protein in lipid metabolism

2012-2015

P. Bartůněk

38

MPO

TIP – FR-TI4/802

Development of novel chemical compounds that can be utilised in antitumour therapy and regenerative medicine

2012-

P. Bartůněk (+ V. Kořínek)

38

TA ČR

TA02010212

ReceptorX: Integrated platform for identification and development of novel drugs

2012-

P. Bartůněk

38

MŠMT

 

Support for infrastructure operation

2012-

P. Bartůněk

38

FP7

261861

 

EU-OPENSCREEN—European Infrastructure of Open Screening Platforms for Chemical Biology

2010-2013

P. Bartůněk

38

GA ČR

GA204/09/0565

Role of  RECQ5 DNA helicase in maintenance of genomic stability

2009-2013

P. Janščák

42

GA ČR

GAP305/10/0281

Role of the Rothmund-Thomson syndrome gene product in maintenance of genomic stability

2010-2014

P. Janščák

42

GA ČR

GA204/09/0565

Role of RECQ5 DNA helicase in maintenance of genomic stability

2009-2013

P. Janščák

42

GA ČR

GAP302/11/1481

Serine proteases of human parasite Schistosoma mansoni and their function in host-parasite interactions

2011-2014

J. Dvořák

43

EU FP7

PIRG05-GA-2009-248642

Schistosoma Protease

2009-2013

J. Dvořák

43

webmaster
 
office